OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO



Status:Completed
Conditions:Arthritis, Arthritis, Cancer, Cancer, Parkinsons Disease, Peripheral Vascular Disease, Renal Impairment / Chronic Kidney Disease, Orthopedic
Therapuetic Areas:Cardiology / Vascular Diseases, Nephrology / Urology, Neurology, Oncology, Rheumatology, Orthopedics / Podiatry
Healthy:No
Age Range:65 - Any
Updated:1/30/2019
Start Date:May 2016
End Date:December 15, 2018

Use our guide to learn which trials are right for you!

The investigators propose a randomized control trial to evaluate long term effects and
effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of
falling in older adults.

Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling,
frailty status, and adverse events

Secondary Endpoints • Characterize the Impact of MBB AFO on spontaneous daily physical
activities • Characterize the feasibility of the MBB AFO device on patient adherence,
acceptability, user-friendliness, and perception of benefit for daily usage


Inclusion Criteria:

- Age 65 or older

- High concerns or high risk of fall

- Ambulatory

Exclusion Criteria:

- Presence of an active wound infection on either of the foot and ankle

- Use of medication or a medical condition that may have unstable (fluctuate over time)
or temporary (less than one month) impact on gait and balance

- Acute fractures on the foot

- Participant of an interventional study within the last 30 days

- Non-ambulatory or unable to stand without help or walk a distance of at least 1.8 m
(~six feet) without assistance

- Major foot amputation

- Unable or unwilling to participate in all procedures
We found this trial at
0
sites